Search

Your search keyword '"Gagne, Matthew"' showing total 172 results

Search Constraints

Start Over You searched for: Author "Gagne, Matthew" Remove constraint Author: "Gagne, Matthew"
172 results on '"Gagne, Matthew"'

Search Results

1. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates

2. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines

3. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

4. Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

6. From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis

7. Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans

8. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

9. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

10. Toward a multi‐layer micro‐structured detector for high‐energy electron radiotherapy.

11. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

13. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

14. Toxicogenomic applications in risk assessment at Health Canada

16. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

17. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

18. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques

19. RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

20. Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques

22. Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques.

23. Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis

24. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

25. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

26. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

27. Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

28. Rapid Detection and Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant in a Returning Traveler

29. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung

30. The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

31. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

32. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates

33. Evaluation of the Relationship between Clonal Hematopoiesis and Severe COVID-19 Disease in Rhesus Macaques

35. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge

36. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

38. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

39. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

40. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates

41. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

42. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters

45. Implicit chaining in cotton-top tamarins Saguinus oedipus)

46. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates

47. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

48. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

49. SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys

Catalog

Books, media, physical & digital resources